Protein name recognition aims to detect each and every protein names appearing in a PubMed abstract. The task is not simple, as the graphic word boundary (space separator) assumed in conventional preprocessing does not necessarily coincide with the protein name boundary. Such boundary disagreement caused by tokenization ambiguity has usually been ignored in conventional preprocessing of general English. In this paper, we argue that boundary disagreement poses serious limitations in biomedical English text processing, not to mention protein name recognition. Our key idea for dealing with the boundary disagreement is to apply techniques used in Japanese morphological analysis where there are no word boundaries. Having evaluated the proposed method with GENIA corpus 3.02, we obtain F-measure of 69.01 on a strict criterion and 79.32 on a relaxed criterion. The result is comparable to other published work in protein name recognition, without resorting to manually prepared ad hoc feature engineering. Further, compared to the conventional preprocessing, the use of morphological analysis as preprocessing improves the performance of protein name recognition and reduces the execution time.
Introduction
Text mining has been one of many alternative approaches to extract and aggregate ''relevant'' information for biomedical research. In the field of molecular biology, genomes of various model species including the human genome have been released. Given such advances, the focus of attention has moved to understanding functions of genes and proteins. In particular, retrieval of published biomolecular interactions, most notably protein-protein interactions, from PubMed abstract (e.g., [8] ) becomes valuable, not only to comprehend the current status but also to plan new biological experiments.
In this paper, we describe protein name recognition, which is a fundamental precursor to biomedical text mining. The task of protein name recognition involves detecting each and every protein name in an abstract. This will facilitate advanced biomedical text processing, such as indexing of protein names within articles, and retrieving evidence passage of biomolecular function descriptions. Accurate protein name recognition may lessen the burden involved in biomolecular database curation.
The main topic of this paper is augmentation of preprocessing so as to attain accurate protein name recognition. We argue that tokenization ambiguity should not be overlooked, by illustrating problems stemming from tokenization in biomedical text. The key idea to deal with tokenization ambiguity is to view biomedical English text as if it were the text of a non-segmented language such as Chinese or Japanese. Our proposal is to apply Japanese morphological analysis techniques to biomedical English text processing. This enables us to resolve tokenization ambiguity as well as part-ofspeech tagging ambiguity. Performance of protein name recognition has been improved when using our morphological analyzer instead of a conventional tokenizer and part-of-speech tagger, which do not take tokenization ambiguity into account.
The rest of paper is organized as follows. Section 2 describes issues in protein name recognition, and Section 3 provides a short review of related work. Together, our motivation to augment preprocessing, i.e., replacing conventional preprocessing by morphological analysis, will be clear. Section 4 gives an overview of a supervised learning approach for protein name recognition, Section 5 presents the core of our proposal, morphological analysis for biomedical text, and Section 6 reports our experimental evaluation of the proposed method. Finally, concluding remarks are given in Section 7.
Issues in protein name recognition
Protein name recognition is a special case of biomedical named entity recognition (NER), and we identify three issues in biomedical NER:
1. Tokenization ambiguity. The graphic word boundary assumed in conventional preprocessing does not necessarily coincide with the protein name boundary. 2. Changing nomenclature. Vocabularies have many variants (a.k.a. synonyms) and are constantly changing over time. However, (a) underlying context are most likely time-invariant though spelling may be slightly altered, and (b) up-to-date expert knowledge resources are publicly available via sequence databases and ontologies. 3. Feature engineering. Protein names and other biomedical NEs share similar orthographic features. Feature engineering to derive effective feature combination (e.g., orthographic feature plus contextual feature) will be necessary to deliver a good performance.
Tokenization ambiguity
In biomedical NER, it is difficult to determine an entity boundary due to tokenization ambiguity. An illustrative example is shown in Fig. 1 .
As we see from Fig. 1 , biomedical NEs are not necessarily segmented by space characters. If we wish to retrieve information about ''B-cell-specific activator protein,'' then the character ''-'' in the graphic word ''protein-binding'' acts as boundaries.
In conventional English processing, a graphic word is taken as a primary unit of text processing. Notion of a graphic word is described in the textbook [13] , and is coined by Kučera and Francis (1967) as ''a string of contiguous alphanumeric characters with space on either side; may include hyphens and apostrophes, but no other punctuation marks.'' Boundaries of graphic words differ from boundaries of biomedical NEs. Hence, biomedical text processing should take note of boundary disagreement, and minimize both under-segmentation and over-segmentation.
Under-segmentation is a situation that arises when a unit could be divided further. In the two strings denoting the same protein complex, T-cell receptor/CD3 complex CD3-T-cell receptor complex graphic words ''receptor/CD3'' and ''CD3-T-cell'' are under-segmented units since they disagree with the boundaries of proteins ''T-cell receptor'' and ''CD3.'' Over-segmentation is a situation that arises when a unit is aggressively divided so that superfluous ambiguity is introduced. Latin origin words such as species name (e.g., ''Homo sapiens,'' ''Escherichia coli'') or academic compound (e.g., ''in vivo,'' ''in vitro'') should not be over-segmented since these are cases where a space character does not truly represents a word separator. Over-segmenting into ''in'' and ''vivo'' introduces unnecessary part-of-speech ambiguity with a common preposition ''in.''
Changing nomenclature
The issue of changing nomenclature has been well recognized in the community. We address the issue based on two observations. The first observation concerns context. The most basic form of context in text processing is part-of-speech. Previous work (e.g., [5, 19] ) used a tokenizer and a part-of-speech tagger tuned to the Penn Treebank Wall Street Journal corpus [17] . Authors in [19] mentioned that part-of-speech annotation was not useful for biomedical NER. We also experienced that such off-theshelf preprocessors tend to be ineffective in protein name recognition, since characteristics of PubMed abstract and Wall Street Journal articles are quite different.
Training part-of-speech taggers on annotated PubMed abstract does partially remedy the problem. Authors in [20] prepared a corpus of 7000 manually tagged abstracts with a new GENE tag, and trained a part-of-speech tagger to extract gene-protein names using transformation-based error-driven learning [2] . Thanks to recent efforts in the community, part-ofspeech annotated PubMed corpora have become available. The subset of the corpus in [20] is released as Task 1A of BioCreAtIve Evaluation [3] . GENIA Corpus 3.02p [16] is also a collection of part-of-speech tagged PubMed abstracts that are publicly available.
The above annotated PubMed corpora follow a tagging specification nearly compliant to the Penn Treebank, which is not intended to cover language phenomena specific to biomedical domain. A strict adherence to the specification, especially graphic words involving symbols (e.g., hyphen(-) or slash (/)), sometimes results in annotation inconsistency. Examples are found in GENIA corpus 3.02p:
granulocyte-macrophage/JJ colony-stimulating/JJ factor/NN; granulocyte/NN macrophage-colony/NN stimulating/ NN factor/NN.
In fact, both of the above annotations are legitimate. Hyphenated words are normally tagged as adjective (JJ), but any token sandwiched between nouns (NN) are tagged as noun (NN). Hyphens are inserted arbitrarily, making tokenization and part-of-speech tagging highly ambiguous. We are confronted by ''data sparsity,'' the critical problem in statistical NLP. As a consequence, it becomes difficult to train a reliable part-of-speech tagger.
The second observation concerns exploitation of external resources. In the biomedical domain, expert knowledge resources are publicly available in the form of sequence databases or ontologies, most of which are constantly updated. Incorporation of the external resources into preprocessing not only increases robustness to spelling variants but also reduces the number of unknown instances.
In a conventional preprocessing of biomedical NER, tokenization, part-of-speech tagging and matching to external resources are regarded as independent subtasks (e.g., [20, 19] ). Entries in the external resources are mostly compounds (i.e., multiple graphic words), and ideally, they should influence tokenization so as to avoid over-segmentation. The pipelined preprocessing cannot deal with such dependency.
Feature engineering
The final issue in biomedical NER is in deciding useful characteristics for protein name recognition. Much effort in adapting NER to the biomedical domain involves exploitation of effective features (e.g., [18] ). Neither effective features nor relative weights of dependent feature interactions is known prior to training. Thus, previous work often selects feature combinations heuristically to deliver a good performance. The approach is not only tedious, but also it may miss some important feature interactions not obvious to human.
Related work
Like our approach (that will be described in the next section), much literature exists that use a supervised learning approach in biomedical NER (e.g., [18, 15, 19] ). Differences in these methods boil down to the type of machine learning algorithm and features being exploited. Our work is distinguished from others in that we acknowledge tokenization ambiguity in biomedical text and propose augmented preprocessing to address the issue.
Alternatives to the supervised learning approach are an approximate string matching approach and a rulebased approach. Although approximate string matching approaches successfully overcame the problem of spelling variants, they suffered from inaccurate boundary detection of biomedical NEs [9] , or applied only to short biomedical NEs [21] . 1 The approaches may not be successful for a complete biomedical NER, since matching longer names means a greater proximity of approximation, where similarity is based only on spelling. In contrast, our tokenization uses exact matching of common substrings against a dictionary of morphological analysis, and chunking can use richer features other than spelling. Hence, our approach is potentially more robust for any given length of biomedical NEs.
The pilot study in a rule-based approach was conducted by [5] , and there are many followers (e.g., [14] ). The approach has an advantage that it does not require annotated corpus. However, protein names and other biomedical NEs share similar orthographic features. It is prohibitive to heuristically enumerate individual rules that classify protein names, where rules are often corre-lated. In contrast, a supervised learning approach can be designed to distinguish protein names from other biomedical NEs. Beside this, the rule-based approaches also used conventional preprocessing which ignored tokenization ambiguity.
A supervised learning approach to protein name recognition

Protein name recognition by chunking
Protein name recognition is casted as a sequential labeling problem (a.k.a. chunking in NLP), and the model of chunk labels is trained in a supervised way. The approach has been successful in similar NLP problems such as base noun phrase bracketing and shallow parsing. Conference on computational natural language learning (CoNLL) holds a shared task contest on those chunking tasks, and chunk labels such as IOB2 are used in those contests [22] .
As shown in Fig. 2 , the supervised learning approach consists of a training phase (vertical arrow) and a testing phase (horizontal arrow). In training, annotated sentences first perform preprocessing, and features are then extracted. These features are used in a supervised machine learning algorithm to train a model. In testing, raw (unannotated) sentences perform the same preprocessing and feature extraction as training, and apply the trained model to obtain the output sentences which are now tagged.
Training data is the GENIA corpus 3.02 where biomedical NEs are hand tagged by biologists (independent of the part-of-speech annotated GENIA corpus 3.02p). In general, chunks are contiguous strings. However, biomedical NEs are not strictly chunks, and may have overlapping or recursive structures, as illustrated in Fig. 1 .
In this paper, we simplify the definition of protein names to chunks, as was done in the BioCreAtIve Task 1A Guideline [3] . We define protein names in GENIA corpus 3.02 as strings which are enclosed by XML semantic tags prefixed with G#protein and are outermost except G#other_names. For example, ''B-cellspecific activator protein'' in <protein>B-cell-specific activator protein</protein> (BSAP) is a recently identified member of the Pax-gene family of transcription factors; in the lymphoid system, BSAP is produced only in B-cells.
is a protein name, but ''B-cell-specific activator protein'' in Using this assay, we also showed that Pax-5d was present in nuclear extracts of some (but not all) B-lymphoid lines and interacts with the <dna><protein> B-cell-specific activator protein<protein>-binding site</dna>.
is not, since ''B-cell-specific activator protein-binding site'' is a DNA fragment.
IOB2 chunk labels from the CoNLL shared task are used to represent protein names. We extend chunk labels to represent position (Inside, Outside, and Begin) and class (protein and term) combined. Five chunk labels B-protein, I-protein, B-term, I-term, and O are used. B-protein and I-protein encode protein names, while B-term and I-term encode outermost biomedical terms (prefixed with G#) that are not protein names. In Fig. 3 , B-cell-specific activator protein and BSAP are encoded by B-protein and I-protein, while Pax-gene family is encoded by B-term and Iterm. We use B-term and I-term to reduce an imbalance of a chunk label distribution in the training data. Otherwise, O labels become too dominant against other labels, generally resulting a poor performance.
Support vector machines
We use support vector machines (SVMs) to train models for chunk labels. SVMs are a binary classifier for a set of training data ðx 1 ; y 1 Þ; . . . ; ðx L ; y L Þ x j 2 R N ; y j 2 fþ1; À1g, where x j is a feature vector of the jth training sample, and y j is the class label associated with the jth training sample. The decision function is defined by where / is a nonlinear mapping function from R N to R H (N ( H), a j ; b 2 R; a j P 0, and SV is a set of support examples. The mapping function / should be designed such that all training examples are linearly separable in R H space. SVMs take a maximal margin strategy in that the parameters are chosen so that the minimum distance between examples and the separating hyperplane (i.e., margin) is maximized.
SVMs have been successful in practical applications by virtue of the kernel trick. Since N ( H, an explicit calculation of a dot product /(x i ) AE /(x) is heavy. However, the dot product can be substituted by a kernel function K(x 1 ,x 2 ) = /(x 1 ) AE /(x 2 ) which implicitly calculates the dot product. With the kernel trick, we have the following decision function:
The kernel we apply is a polynomial kernel which is defined as
The polynomial kernel expands conjunctive features implicitly without loss of generality nor an increase in computational costs. We use a quadratic kernel (d = 2) which implies that feature combinations of size 1 and 2 are automatically considered. This is particularly desirable in protein name recognition, since we do not have to resort to ad hoc feature engineering of effective feature combinations. Protein name recognition is a multi-label classification. Extending from a binary label classification to a multi-label classification is necessary. For this, we use a pair-wise method that constructs k C 2 binary classifiers. Since there are five chunk labels, k = 5.
Our challenge: augmented preprocessing
The performance of protein name recognition depends on feature extraction, which in turn, relies on preprocessing (cf. Fig. 2 ). Out of three issues described in Section 2, feature engineering can be done without heuristic-driven feature selection by choosing SVMs and the polynomial kernel as our supervised learning algorithm. Remaining issues, tokenization ambiguity and changing nomenclature, relate to preprocessing. Our proposal is to apply Japanese morphological analysis techniques to biomedical English text so that both tokenization and part-of-speech tagging can be tuned for the biomedical domain.
Morphological analyzer for biomedical text processing
Markov model
Our morphological analyzer is a classic Markov model trained on a part-of-speech annotated corpus. It constructs a trellis where each node is a substring coupled with its part-of-speech, and uses the Viterbi algorithm to select an optimal path in the trellis which corresponds to a segmentation with the maximum generation probability.
An example trellis built for a sentence beginning with ''B-cell-specific activator protein-binding site'' is illustrated in Fig. 4 . Each box contains substring (''B-cell''), part-of-speech (''NN'') and word observation cost (''6301'') converted from word observation probability. The part-of-speech tags nearly follow the Penn Treebank tagging guideline with some modifications described in Section 5.2. There are virtual boxes ''BOS'' and ''EOS'' for the begin and the end of a sentence Fig. 3 . IOB2 chunk labels to represent biomolecular names. Preprocessing determines tokenization (indicated by lines) and part-of-speech (written as Penn Treebank style). In training, chunk labels where position and class are combined (e.g., B-protein) will be annotated. In testing, the position part of the estimated chunk label determines boundary and the class part decides if the substring is of protein, term or the other class.
respectively. Numbers in a box relate to a word observation probability, i.e., the probability of a word given a tag, while numbers on an edge relates to a tag connection probability, i.e., the probability of the current tag given the two previous tags. A formal derivation will be presented later. It is important to note that the trellis can represent both tokenization ambiguity (''B-cell'') and part-of-speech ambiguity (''binding''), as shown in Fig. 4 .
Formally, the task of morphological analysis is to find a word sequence
n that maximize the probability of AEW * ,T * ae defined as:
¼ arg max
Parameters to estimate from an annotated corpus are decomposed into tag connection probability p(t i |t iÀ2 ,t iÀ1 ) and word observation probability p(w i |t i ). They are substituted by counting frequencies in the training corpus:
Had we directly used probabilities, we would suffer from underflow in calculation, as probabilities for a long sentence become extremely low. To remedy this, we convert the probability to the cost which is defined as a log of an inverse of the probability. As a result, maximizing the probability product becomes minimizing the cost addition. Now, Eq. (7) becomes
¼ arg min
Numbers in Fig. 4 are actual costs calculated from probabilities.
In summary, our morphological analyzer gives an ''optimal'' segmentation with part-of-speech annotation, statistically resolving both tokenization ambiguity and part-of-speech ambiguity.
Corpus modification for better parameter estimation
For parameter estimation, we use the GENIA 3.02 merged corpus 2 of biomedically annotated corpus 3 and part-of-speech annotated corpus 4 . Note that token boundaries in the part-of-speech annotated corpus are automatically determined by the Penn Treebank tokenizer, 5 while NE boundaries in the biomedically annotated corpus are manually determined by biologists. Boundary disagreement is removed in the merged corpus by dividing tokens in the part-of-speech annotated corpus to be consistent with NE boundaries in the biomedically annotated corpus. Table 1 summarizes the number of observed disagreements for each biomedical NE tag in the merged corpus. All are victims of undersegmentation.
Under-segmentation instances should be removed from the corpus as they appear to be harmful to biomed- ical NER. Fine-grained tokens also help to reduce data sparsity and to increase consistency for graphic words with symbols. With this in mind, the merged corpus is modified as follows: Symbols in biomedical text have arbitrary usage and it is hard to determine their usage from the context. We introduce lexicalized tags 6 for symbols to reduce under-segmentation and annotation inconsistency. Symbols ''-,'' ''/,'' and ''+'' are tentatively made as lexicalized tags. s granulocyte-macrophage/JJ figranulocyte/NN -/-macrophage/NN In biomolecular names, Roman and Greek alphabets are used interchangeably. For example, ''B'' in ''NFkappa B'' and ''beta'' in ''NF kappa beta'' are synonymous. We introduce a new part-of-speech tag (@) for a Roman and Greek alphabet. s NF-kappa/NN B/NN fiNF/NN -/-kappa/@ B/@ Units frequently appear in scientific publication including PubMed abstracts. They are sometimes tagged as noun (NN) and sometimes tagged as adjective (JJ) in the part-of-speech annotated corpus. The underlying rules for the part-of-speech ambiguity was not obvious to us. We introduce a new part-of-speech tag (UN) for units, to reduce annotation inconsistency in the corpus. s Examples of units are kDa, mg, . . . Tokens that were consecutively tagged as foreign word (FW) in the original are merged into a single token with the part-of-speech (FW). Our intention is to reduce over-segmentation. s in/FW vivo/FW fiin vivo/FW
Dictionary management
Since we treat biomedical English text as if it were Japanese, we make no assumption about delimiting characters during construction of a trellis. Although segmentation is possible at each character in Japanese, segmentation in biomedical English is admissible only in certain cases. We limit the potential tokenization ambiguity to occur around the cases below in addition to a default space character:
Symbols: delimit at / in ''TCR/CD3 complex'' Numbers: delimit at 2 in ''IL2'' Change of case: delimit at B in ''NF-kappaB''
The rest of trellis construction follows the same procedure as Japanese morphological analysis [23] . The dictionary is organized in a TRIE structure. We apply common prefix search to the dictionary where entries can be compounds that include a space character (e.g., ''B-cell''). The common prefix search efficiently retrieves all substrings sharing the same prefix as the query string. We use a Double Array as our implementation of the TRIE [1] .
By this mechanism, under-segmentation is reduced by defining admissible segmentation cases consisting of more than just a space character. Moreover, the dictionary allows entries which include a space character in between since a space character is not a default delimiter. Thus, external resources containing multiple graphic words can be imported into a dictionary, and tokenization which avoids over-segmentation becomes possible.
As a case study to enhance a dictionary of our morphological analysis, we incorporate the latest GOA gene_association.goa_human.gz (release of November 11, 2003) [7] into the dictionary. GOA contains associations between the vocabulary of GO and a non-redundant set of proteins described in the SWISS-PROT, TrEMBL, and Ensembl databases. This collectively provides complete proteomes for Homo sapiens. Since GENIA corpus 3.02 is indexed with MeSH terms ''Human,'' ''Blood Cells,'' and ''Transcription Factor,'' we find this external resource appropriate for our protein name recognition. For a new entry from GOA not observed in GENIA part-of-speech annotated corpus, the part-of-speech is assigned to noun (NN), and the word observation probability is set to the half of the minimum word observation probability of noun (NN) calculated from the annotated corpus. Hence, the probability of the new GOA entry is set to the half of the minimum noun word observed in GENIA corpus.
Experimental results
Data
GENIA corpus 3.02 contains 1998 abstracts once we remove duplicated abstracts. We order abstracts by MEDLINE IDs to obtain an effect of chronological sorting, and split them into 10 sets. A general policy is to train a model on an older set of abstracts and to test it on a newer set of abstracts so as to simulate a situation where protein name recognition is applied.
In our experiments, the latest 205 abstracts are used for testing. Two sets of data are prepared for training-small and large. The small training data consists of 594 abstracts from the beginning, while the large training data consists of 1793 abstracts from the beginning. The former is used to compare various results in experimental settings, especially to examine the effect of tokenization to protein name recognition and robustness to detecting unknown protein names. The latter is intended for other research groups to compare our result with the standard data split using GENIA corpus 3.02. Table 2 summarizes various experimental settings. First, we wish to estimate an upper bound of protein name recognition using GENIA corpus 3.02. The ideal 1 uses annotated information from the merged corpus with error-free tokenization and curated part-of-speech annotation for biomedical NER. The ideal 2 uses annotated information from the original part-of-speech annotated. This may contain under-segmented tokenization but curated part-of-speech annotation.
Preprocessing
Next, we examine how much our augmented preprocessing can be comparable to an ''ideal'' preprocessing. The 594 abstracts of the modified GENIA described in Section 5.2 was used to train our morphological analyzer. The proposed 1 refers to a closed setting and the proposed 2 refers to an open setting. In the open setting, the external resource GOA is added to the dictionary. Finally, we evaluate how our augmented preprocessing performs against conventional preprocessing. As for conventional preprocessing, we use the Penn Treebank tokenizer and a part-of-speech tagger trained by the fnTBL package [6] (transformation-based error-driven learning, but a faster implementation of Brill Tagger), since they are typically used in other publications (e.g., [5, 20] ). The conventional 1 uses Sections 15-19 of the Penn Treebank Wall Street Journal for training, while the conventional 2 uses the 594 abstracts of the original GENIA part-of-speech annotated corpus.
Feature extraction
Since our purpose is to examine the efficacy of preprocessing, we keep features that can only be extracted from the result of preprocessing:
Part-of-speech annotation (POS) Cue word (CUE). This is also refereed to as ''f-terms'' in [5] . We count co-occurrence frequency of semantic tag (G#) and all tokens in the corpus, and apply a standard statistical hypothesis test to select tokens that co-occur more frequently than by chance. Table  3 shows a subset of characteristic tokens for semantic tag. For each characteristic token in Table 3 , we record its associated semantic tags to the comment field of a dictionary of our morphological analyzer. Table 2 Experimental settings for various preprocessing Training corpus Externals Tokenization Part-of-speech tagging ideal 1 n/a n/a Curated Curated ideal 2 n/a n/a Graphic word Curated
Modified GENIA GOA MM morphological analyzer conventional 1 PTB None PTB tokenizer TBL conventional 2 GENIA None PTB tokenizer TBL ''Training corpus'' means a part-of-speech annotated corpus used in training, and ''externals'' means if we use external resources. ''PTB'' stands for the Penn Treebank, and ''GOA'' stands for Gene Ontology Association. ''Tokenization'' is how we segment raw(unannotated) sentences in testing, and ''part-of-speech tagging'' is the method of part-of-speech taggers in testing. ''MM'' stands for Markov model, and ''TBL'' stands for transformation-based error-driven learning. For example, the comment field of the entry ''kinase'' in the dictionary contains its associated semantic tags such as ''G#_protein.'' This feature is activated if there is a semantic tag listed in the comment field. External resource (GOA). For each new entry imported from GOA, we record ''GOA_HUMAN'' to the comment field of a dictionary of our morphological analyzer. This feature is activated if there is a ''GOA_HUMAN'' listed in the comment field.
The role of the comment field is to associate non-linguistic information with linguistic (part-of-speech) annotation for each token segmented by a morphological analyzer. Recall that the morphological analyzer segments a sentence into tokens, and annotates the most basic form of linguistic feature POS for each segmented token. By embedding non-linguistic features CUE and GOA in the comment field of the dictionary used in the morphological analyzer, we can annotate linguistic and non-linguistic information simultaneously. Features can be extracted without additional preprocessing. Preprocessing in proposed 1 and proposed 2 are done in this way.
In contrast, conventional preprocessing needs pipelined modules to obtain linguistic feature POS and non-linguistic features CUE and GOA for each token. Thus, we execute a tokenizer, followed by a part-ofspeech tagger, and apply a separate module to match each token against cue words and GOA entries in conventional 1 and conventional 2.
Training
To train the model of chunk labels in a supervised way, we use a SVM-based chunker, YamCha [12] , which is an open source software. Parameters used in YamCha are as follows. In all settings, the context window size is set to 2, i.e., information is extracted from tokens positioned À2, À1, 0 (focal token), +1, +2, and are converted to feature vectors. A chunking direction are set to forward, which means that chunk labels are estimated from the top of the sentence. A fuller description of chunking with SVMs can be found in [10] .
Elements in features vectors represent simple features obtained in Section 6.3, prefixed with the position (À2, . . ., +2). Combination of features (conjunctive features) are implicitly expanded by the polynomial kernel.
Results
Results are evaluated on four criteria: strict, left, right, and either. The strict counts correct if both sides of protein name boundaries are correct and the either counts correct if either side of protein name boundaries is correct. The left/right counts correct if left/right side of protein name boundary is correct. Relaxed criteria (either, left, and right) are used to account for annotation inconsistency of protein name boundaries in the corpus. A typical example of annotation inconsistency is that a token ''protein'' in trailers is sometimes annotated as a part of G#protein, and sometimes annotated as outside G#protein. We view that the true performance of protein name recognition lie between strict and either criteria. To quantify the performance, we use standard measures of precision, recall and Fmeasure (F b = 1 ). Table 4 shows results with the large training dataset. Our protein name recognition achieves an F-measure of 69.01 on strict criterion. F-measure goes up about 5 points when relaxing criteria to left or right side, and about 10 points when relaxing criterion to either side. The result on either criterion (F-measure of 79.32) suggests that the protein name recognition could be used to support biomolecular database curation involving PubMed abstracts. We stress that a reasonable performance is attained just by augmenting preprocessing, and without resorting to ad hoc feature engineering. Table 5 shows results with the small training dataset. Our augmented preprocessing (proposed 1 and proposed 2) give better results than conventional preprocessing (conventional 1 and conventional 2), by 1 point improvement on strict criterion and 3.5 point improvement on either criterion. On strict criterion, our augmented preprocessing gives nearly the same performance as ideal 2 where only part-of-speech is curated by annotators. On either criterion, our augmented preprocessing gives nearly the same performance as ideal 1 where both tokenization and part-of-speech are curated by annotators. Recall that ideal 1 is an estimated upper bound of protein name recognition with GENIA corpus 3.02. Thus, effectiveness in the use of morphological analysis, which (P for precision, R for recall and F for F-measure).
addresses tokenization ambiguity and changing nomenclature, is experimentally confirmed.
There are other interesting observations in Table 5 . First, we compare results between ideal 1 and ideal 2 where the difference is whether a boundary disagreement was curated by a human or not. (NB. The amount of boundary disagreement is summarized in Table 1 .) The result indicates that tokenization ambiguity influences the performance of protein name recognition. Turning to proposed 1 and proposed 2 in Tables 4 and 5 , the performance improves when a large dataset is allowed for training. However, only a small difference is observed when a dictionary of morphological analysis is enhanced with GOA entries. We still need to investigate effective exploitation of external resources. Finally, we compare results between conventional 1 and conventional 2 where the difference is the training corpus-''in-domain'' (GENIA) or ''out-of-domain'' (Penn Treebank). Performance is slightly improved when preprocessing is trained on ''in-domain'' part-of-speech annotated corpus, which agrees with the previous work.
Discussion
We examine how these learned models are robust against ''unknown'' protein names. By unknown, we mean that the protein names are only found in the training data of 594 abstracts. There are 1876 instances in the test data. Table 6 shows the results of unknown protein name recognition on strict criterion. Except ideal cases, proposed 2 of the open setting achieves the best recall (40.35), and conventional 1 trained on Penn Treebank achieves the best precision (56.59). Under a simulated situation of changing nomenclature, we observe a trend that our augmented preprocessing gives better recall while conventional preprocessing gives better precision.
Our morphological analyzer attempts to avoid undersegmentation and produces fine-grained tokens. This implies that the dimension of the feature space from our augmented preprocessing becomes lower than the dimension of feature space from conventional preprocessing. The dimensions of feature space for proposed 2 and conventional 2 are 20,076 and 24,961, respectively. The model of proposed 2 tends to be more generalized, and a better recall is obtained. On the other hand, a lower precision is due to the fine-grained tokenization in that narrower neighboring substrings are converted to feature vectors than in conventional preprocessing. We still need to investigate a good balance between precision and recall for unknown protein name recognition.
Finally, we compare execution speed of preprocessing. Sixteen thousand four hundred and sixty seven sentences from 1998 abstracts were processed on a 2.20 GHz processor with 1 GB memory. Table 7 shows the cpu time taken. Our morphological analyzer is substantially faster than conventional preprocessing. The gain in speed is important when we need to process voluminous texts such as PubMed abstracts. 
Conclusions and future work
We propose the use of morphological analysis in protein name recognition. Our contributions are (1) to illustrate problems stemming from conventional preprocessing, in particular boundary disagreement which has been overlooked in biomedical text processing, and (2) to propose morphological analysis as a way to overcome the problems. We obtain F-measure performance of 69.01 on a strict criterion and 79.32 on a relaxed criterion with GENIA corpus 3.02. We show that our augmented preprocessing improves the performance of protein name recognition over conventional preprocessing.
A major limitation of our work is that our protein name recognition requires a labor-intensive annotated corpus, as it is a supervised learning approach. To increase both accuracy and coverage, we will need to investigate ways to apply a semi-or un-supervised approach that effectively uses ample unlabeled data, as proposed in [4] . Another criticism with supervised learning approaches, especially SVMs, is scalability. SVMs show excellent performance in terms of accuracy, but are generally slow to execute. Recently, authors in [11] have proposed an approximation method for text analysis with the polynomial kernel, which makes trained classifiers substantially faster while keeping the same level of accuracy. Such research development is on-going in NLP (and Bioinformatics), we envision that the issue of scalability will not be critical in near future.
As future work, a possible direction is linking a protein name to a protein sequence. Our protein name recognition detects protein names in an abstract. A next step to assist database curators will be to suggest candidates of corresponding protein sequences. A similar line of motivation is found in Task 1.B of BioCreAtIve Evaluation where the task is to create the list of unique genes that are mentioned in an abstract referenced by a model organism database. Our morphological analyzer partially facilitates cross-linking by inserting accession IDs in a comment field of the relevant entry in the dictionary. It would be interesting to investigate ways to achieve accurate assignment of sequence IDs. 
